Archive | Interviews RSS feed for this section

Starting with Pep: An Early-Stage Conversation with Creative Bio-Peptides

8 Apr

By Rory McCann, Marketing Manager & Conference Producer, LSN

Creative Bio-Peptides is an early-stage company, founded and led by Dr. Michael Ruff, with a mission to improve lives through developing oral receptor-active peptides targeting neurodegenerative diseases. We spoke with Chief Business Officer, Michael Simon about the early-stage journey of Creative Bio-Peptides – how it was started, what their strategy looks like today, and where they see the company going forward.

Creative Bio-Peptides is a past participant at an Redefining Early Stage Investments (RESI) partnering event. Learn more about RESI and sign up by April 9 to save $100 on super early bird rates.

What Successful Partnering Really Looks Like: A Conversation with Neuro20 Technologies

18 Feb

By Rory McCann, Marketing Manager & Conference Producer, LSN

When fundraising executives seek out a successful partnering experience, so many define success with deals and checks. At Life Science Nation, we frequently hear success stories that do end with capital and funding, but many do not. Instead, these stories touch on the benefits of successful partnering that impact company growth and bottom line in other ways, often the details that are taken for granted when seeking strategic partners.

Neuro20 Technologies is one such success story. They attended their first digital RESI conference looking for capital but came out with so much more. Listen to their story, and sign up for Digital RESI JPM to learn more from the Neuro20 Technologies team and start your partnering success story!

Partnering in the Age of AgeTech: What the Longevity Market is Missing

7 Jan

By Rory McCann, Marketing Manager & Conference Producer, LSN

The Inaugural Longevity, Health & Innovation digital partnering event launches next week! This conference, co-organized by Life Science Nation (LSN) and Mary Furlong & Associates (MFA), is designed to bring early-stage companies and investors together, along with industry leaders, to advance deals in the longevity marketplace in order that seniors live longer, healthier lives.

I spoke with LSN CEO, Dennis Ford and MFA CEO, Dr. Mary Furlong on their partnership and thoughts on the industry, particularly where Longevity, Health & Innovation fills the gap in the early-stage ecosystem. There is still time to sign up and begin meeting with leaders in the field – Learn more at https://longevityhealthinnovation.com/.

A Conversation with Helena Cowley, CEO of Oxidien Pharmaceuticals

3 Dec

By Rory McCann, Marketing Manager & Conference Producer, LSN

Helena Cowley, MS, MBA is CEO of Oxidien Pharmaceuticals, a therapeutics company mitigating kidney stone disease by using enzyme compounds to treat secondary hyperoxaluria. We recorded our chat about the early days of Oxidien and how they’ve navigated the fundraising landscape. We discuss conferences, networking, and tools to give early-stage companies an edge when meeting with strategic partners.

To learn more about RESI and Life Science Nation’s premier partnering events this September, visit www.resipartneringweek.com. Digital RESI Partnering Week September super early bird rates apply until July 23, so sign up today to start meeting with investors and strategic partners to jumpstart your 2021 fundraising goals!

 

Why Failure is Falling Upwards ​​​​​​​– Learn from Entac Medical Founder, Buddy Lyons, and Find Out How RESI became Part of the Success Story

19 Nov

By Rory McCann, Marketing Manager & Conference Producer, LSN

Failure is an unwelcome companion on the entrepreneurial journey, and one most founders avoid at all costs. To Buddy Lyons, Founder and CEO of Entac Medical, failure (or the threat of it) can play an integral role in a company’s development, growth, and eventual success. Entac Medical is developing non-invasive devices for diagnosis, particularly to surgical patients. Hear their story and listen to my conversation with Buddy about the earliest days of Entac, and what got them through the most trying times.

Partnering with IGIA Pharmaceuticals

5 Nov

By Rory McCann, Marketing Manager & Conference Producer, LSN

In this interview, I sit down to chat with Dr. Jeff Livingstone on his recent move to CEO of Igia Pharmaceuticals, and how partnering events continue to serve his companies, even as an industry veteran. Jeff shares insight into the early days of Igia, and how he uses partnering to expand their goals and reach children and families affected by rare and orphan diseases, specifically Noonan Syndrome.
Listen to the conversation and learn more about RESI November and Healthtech Partnering Week.

Standing Out among Partnering Platforms

29 Oct

An Interview with Dennis Ford, CEO, LIfe Science Nation

By Rory McCann, Marketing Manager & Conference Producer, LIfe Science Nation


It’s no secret that while the traditional partnering and event model has taken a hit this year, life-saving deal-making is still in full swing. In fact, the need for innovation in life science and healthcare may be the key to a return to normalcy. As we round the corner into 2021, digital partnering conferences dot the landscape of what remains an unknown future. Armed with more data and a better understanding of what successful digital partnering looks like than we had six months ago, I sat down to speak with Life Science Nation (LSN) CEO, Dennis Ford on what makes the LSN partnering experience stand out, as well as the hidden value that makes all the difference.

Listen below to find out more about RESI Partnering Platforms

To learn more and sign up for Digital RESI November, visit http://www.resiconference.com. Explore LSN’s upcoming Healthtech Partnering Week at www.healthtechpartneringweek.com.

← Older Entries
Newer Entries →